Kazia Therapeutics (KZIA) Amortization (2009 - 2025)
Kazia Therapeutics (KZIA) posted Amortization of $233438.2 for Q4 2025, up 164.3% on a QoQ basis from $88322.8 in Q2 2025.
Kazia Therapeutics (KZIA) has 4 years of Amortization data on file, last reported at $233438.2 in Q4 2025.
- In Q4 2025, Amortization changed N/A year-over-year to $233438.2; the TTM figure through Dec 2025 stood at $233438.2 (changed N/A YoY), while the FY2025 annual figure was $88322.8, changed N/A from the prior year.
- Amortization rose to $233438.2 in Q4 2025, from $88322.8 in the prior quarter.
- Across five years, Amortization topped out at $233438.2 in Q4 2025 and bottomed at $88322.8 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.75 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Kazia Therapeutics | 1.55 Bn | 1.55 Bn | - | 233,438.21 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 233,438.21 |
| Dec 31, 2025 | 233,438.21 |
| Jun 30, 2025 | 88,322.78 |
| Jun 30, 2025 | 88,322.78 |
| Dec 31, 2011 | 2.03 Mn |
| Dec 31, 2011 | 2.03 Mn |
| Dec 31, 2010 | 1.99 Mn |
| Dec 31, 2010 | 1.99 Mn |
| Dec 31, 2009 | 8.30 Mn |
| Dec 31, 2009 | 8.30 Mn |